Healy PJ and Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis ...
In enthesitis and/or dactylitis ... should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be ...
Here’s what you can do. If you live with psoriatic arthritis (PsA), you’re likely aware that it doesn’t just take a physical toll. The physical and emotional effects of the condition can ...
Progression of Psoriatic Arthritis and Shared Decision-Making ... The first is that synovitis and enthesitis in MSUS can predict radiographic progression and worsening of patient-related outcomes.
No new safety concerns were observed through 16 weeks among pediatric patients with juvenile psoriatic arthritis or enthesitis-related arthritis receiving ixekizumab. Ixekizumab (IXE) demonstrated ...
Apremilast (APR) shows significant efficacy and safety over 48 weeks for the management of early oligoarticular psoriatic arthritis (PsA), according to study results presented at the American College ...
While it's not entirely clear which psoriasis patients will develop psoriatic arthritis, the presence of psoriasis provides an opportunity to identify those at risk and possibly intervene ...
Musculoskeletal ultrasonography (MSUS) has aided greatly in the diagnosis and treatment of rheumatic conditions, including psoriatic arthritis. But the value should be weighed against certain ...
“Spondyloarthritis” is an umbrella term for inflammatory conditions that cause arthritis. Examples include ankylosing spondylitis and psoriatic arthritis. Spondyloarthritis is a group of ...
I think that for psoriatic arthritis, we do tend to think of these ... skin disease under control, there is no enthesitis and no dactylitis, is how long do I have to be on this stock?